来自MSN1 个月
Scientists propose CDK2 enzyme as new target for cancer therapy
More information: Vishnu Kumarasamy et al, Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle, Nature Communications (2025). DOI: 10. ...